1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. C4 THERAPEUTICS INC
C4 Therapeutics Inc
XNAS: CCCC
3.39 -0.03 (-0.88%)
1.6M
XNAS Volume

XNAS 18 Sep, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert

C4 Therapeutics Inc - CCCC - stock price prediction, stock price target, analyst ratings from 7 analysts

C4 Therapeutics Inc has a share price target of US$ 13, revenue growth forecast of -28.4%, and profit growth estimate of -10.8% for FY26, based on top 7 analyst calls.